Wegovy (semaglutide) Approval Letter
FDA approved Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
Not legal or medical advice.
This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.
U.S. Food and Drug AdministrationApproval letterApproved
- Docket / Citation
- NDA 215256
- Published
- 2021-06-04
- Effective
- 2021-06-04